Abingworth LLP Vera Therapeutics, Inc. Put Options Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$181 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$165 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$140 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$117 Million11.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.58MShares$108 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.13B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...